Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data
Abstract
The current interest in undertaking cost‐effectiveness analyses alongside clinical trials has lead to the increasing availability of patient‐level data on both the costs and effectiveness of intervention. In a recent paper, we show how cost‐effectiveness analysis can be undertaken in a regression framework. In the current paper we develop a direct regression approach to cost‐effectiveness analysis by proposing the use of a system of seemingly unrelated regression equations to provide a more general method for prognostic factor adjustment with emphasis on sub‐group analysis. This more general method can be used in either an incremental cost‐effectiveness or an incremental net‐benefit approach, and does not require that the set of independent variables for costs and effectiveness be the same. Furthermore, the method can exhibit efficiency gains over unrelated ordinary least squares regression. Copyright © 2003 John Wiley & Sons, Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A SURE model will be used to allow for correlated residuals of the cost and effect equations while adjusting for potential confounders such as baseline differences in utility scores.
“We will use a SURE model (seemingly unrelated regression equations) to allow for correlated residuals of the cost and effect equations while adjusting for potential confounders (eg, baseline differences in utility scores).110”
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193 · see citing works
Stein, L. I. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780170034003 · Cited by 1,902 · see citing works
The Importance of the Normality Assumption in Large Public Health Data Sets
Lumley, T., Diehr, P., Emerson, S., & Chen, L. (2002) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.23.100901.140546 · Cited by 1,803 · see citing works
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,621 · see citing works
Estimating log models: to transform or not to transform?
Manning, W. G., & Mullahy, J. (2001) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00086-8 · Cited by 1,145 · see citing works
Stinnett, A. A., & Mullahy, J. (1998) · Medical Decision Making · doi:10.1177/0272989x98018002s09 · Cited by 1,103 · see citing works
Costs, effects and C/E‐ratios alongside a clinical trial
van Hout, B. A., Al, M., Gordon, G. S., & Rutten, F. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 963 · see citing works
How should cost data in pragmatic randomised trials be analysed?
Thompson, S. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1197 · Cited by 772 · see citing works
Multivariate Analysis: With Applications in Education and Psychology.
Duncan, G. T., & Timm, N. H. (1977) · Journal of the American Statistical Association · doi:10.2307/2286946 · Cited by 566 · see citing works
Hoch, J. S., Briggs, A. H., & Willan, A. R. (2002) · Health Economics · doi:10.1002/hec.678 · Cited by 535 · see citing works
Self-citationOʼBrien, B. J., Drummond, M., Labelle, R. J., & William, A. (1994) · Medical Care · doi:10.1097/00005650-199402000-00006 · Cited by 404 · see citing works
Assertive community treatment: an update of randomized trials
Burns, B. J., & Santos, A. B. (1995) · Psychiatric Services · doi:10.1176/ps.46.7.669 · Cited by 396 · see citing works
Using Conjoint Analysis to Assess Women's Preferences for Miscarriage Management
Ryan, M., & Hughes, J. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199705)6:3 · Cited by 340 · see citing works
Comparability of Randomised Groups
Altman, D. G. (1985) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2987510 · Cited by 329 · see citing works
A Randomized Trial of Assertive Community Treatment for Homeless Persons With Severe Mental Illness
Lehman, A. F. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230076011 · Cited by 263 · see citing works
Assertive Community Treatment and Case Management for Schizophrenia
Scott, J. E., & Dixon, L. B. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.4.657 · Cited by 226 · see citing works
Assertive Community Treatment: An Evaluation of the Experimental Evidence
Olfson, M. (1990) · Psychiatric Services · doi:10.1176/ps.41.6.634 · Cited by 207 · see citing works
On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses
Phelps, C. E., & Mushlin, A. I. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300004803 · Cited by 173 · see citing works
A Note on Confidence Intervals in Cost-Effectiveness Analysis
Tambour, M., Zethraeus, N., & Johannesson, M. (1998) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300011442 · Cited by 156 · see citing works
Down and out: estimating the relationship between mental health and unemployment
Hamilton, V. H., Merrigan, P., & Dufresne, É. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199707)6:4 · Cited by 147 · see citing works
Self-citationConfidence intervals for cost/effectiveness ratios
Wakker, P. P., & Klaassen, M. P. (1995) · Health Economics · doi:10.1002/hec.4730040503 · Cited by 133 · see citing works
Cost-effectiveness of assertive community treatment for homeless persons with severe mental illness
Lehman, A. F., Dixon, L. B., Hoch, J. S., DeForge, B. R., Kernan, E., & Frank, R. G. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.4.346 · Cited by 126 · see citing works
Self-citationO'Hagan, A., & Stevens, J. W. (2003) · Health Economics · doi:10.1002/hec.699 · Cited by 119 · see citing works
Incremental net benefit in randomized clinical trials
Willan, A. R., & Lin, D. Y. (2001) · Statistics in Medicine · doi:10.1002/sim.789 · Cited by 107 · see citing works
Self-citationA Bayesian approach to sensitivity analysis
Felli, J. C., & Hazen, G. B. (1999) · Health Economics · doi:10.1002/(sici)1099-1050(199905)8:3 · Cited by 77 · see citing works
Fieller's method and net health benefits
Heitjan, D. F. (2000) · Health Economics · doi:10.1002/1099-1050(200006)9:4 · Cited by 65 · see citing works
The social value of health programmes: is age a relevant factor?
Rodriguez, E. M., & Prades, J. L. P. (2000) · Health Economics · doi:10.1002/1099-1050(200010)9:7 · Cited by 63 · see citing works
Willan, A. R. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00110-6 · Cited by 59 · see citing works
Self-citationAs a matter of fact: evidence-based decision-making unplugged
Birch, S. (1997) · Health Economics · doi:10.1002/(sici)1099-1050(199711)6:6 · Cited by 53 · see citing works
Cost effectiveness of antenatal anti-D prophylaxis
Vick, S., Cairns, J., Urbaniak, S. J., Whitfield, C. R., & Raafat, A. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199607)5:4 · Cited by 30 · see citing works
Self-citationMullahy, J. (1996) · PubMed · Cited by 21 · see citing works
Briggs (1998) · doi:10.1002/(sici)1099-1050(199812)7:8
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Manca, A., Hawkins, N., & Sculpher, M. J. (2005) · Health Economics · doi:10.1002/hec.944 · Cited by 1,024 · see citing works
Faria, R., Gomes, M., Epstein, D., & White, I. R. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0193-3 · Cited by 673 · see citing works
Early, Goal-Directed Therapy for Septic Shock — A Patient-Level Meta-Analysis
The PRISM Investigators (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701380 · Cited by 600 · see citing works
Rodgers, H., Bosomworth, H. J., Krebs, H. I., van Wijck, F., Howel, D., Wilson, N., Aird, L., Alvarado, N., Andole, S. N., Cohen, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31055-4 · Cited by 488 · see citing works
Riley, R. D., Abrams, K. R., Lambert, P. C., Sutton, A. J., & Thompson, J. R. (2006) · Statistics in Medicine · doi:10.1002/sim.2524 · Cited by 195 · see citing works
Nixon, R., Wonderling, D., & Grieve, R. (2010) · Health Economics · doi:10.1002/hec.1477 · Cited by 194 · see citing works
IMPROVE Trial Investigators (2017) · BMJ · doi:10.1136/bmj.j4859 · Cited by 163 · see citing works
Statistical Analysis of Cost‐effectiveness Data
Willan, A. R., & Briggs, A. H. (2006) · doi:10.1002/0470856289 · Cited by 155 · see citing works
Self-citationDeveloping Appropriate Methods for Cost-Effectiveness Analysis of Cluster Randomized Trials
Gomes, M., Ng, E. S. W., Grieve, R., Nixon, R. M., Carpenter, J. R., & Thompson, S. G. (2011) · Medical Decision Making · doi:10.1177/0272989x11418372 · Cited by 153 · see citing works
Hartman, E., Grieve, R., Ramsahai, R. R., & Sekhon, J. S. (2015) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12094 · Cited by 145 · see citing works
Handoll, H. H., Brealey, S., Rangan, A., Keding, A., Corbacho, B., Jefferson, L., Chuang, L., Goodchild, L. M., Hewitt, C. E., & Torgerson, D. J. (2015) · Health Technology Assessment · doi:10.3310/hta19240 · Cited by 148 · see citing works
Kleiboer, A., Smit, J., Bosmans, J., Ruwaard, J., Andersson, G., Topooco, N., Berger, T., Krieger, T., Botella, C., Baños, R., et al. (2016) · Trials · doi:10.1186/s13063-016-1511-1 · Cited by 133 · see citing works
Miyamoto, G. C., Franco, K. F. M., van Dongen, J. M., Franco, K. F. M., de Oliveira, N. T. B., Amaral, D. D. V., Branco, A. N. C., da Silva, M. L., van Tulder, M. W., & Cabral, C. M. N. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098825 · Cited by 130 · see citing works
Nixon, R. M., & Thompson, S. G. (2005) · Health Economics · doi:10.1002/hec.1008 · Cited by 128 · see citing works
van der Meij, E., Anema, J. R., Leclercq, W. K. G., Bongers, M. Y., Consten, E. C. J., Schraffordt Koops, S. E., van de Ven, P. M., Terwee, C. B., van Dongen, J. M., Schaafsma, F. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31113-9 · Cited by 114 · see citing works
Orgeta, V., Leung, P., Yates, L., Kang, S., Hoare, Z., Henderson, C., Whitaker, C. J., Burns, A. S., Knapp, M. R. J., Leroi, I., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19640 · Cited by 125 · see citing works
Clare, L., Kudlicka, A., Oyebode, J. R., Jones, R. W., Bayer, A., Leroi, I., Kopelman, M., James, I. A., Culverwell, A., Pool, J., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23100 · Cited by 123 · see citing works
An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis
Hunter, R. M., Baio, G., Butt, T., Stephen Morris, A., Round, J. A., & Freemantle, N. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0247-6 · Cited by 114 · see citing works
Manca, A., & Palmer, S. (2005) · Applied Health Economics and Health Policy · doi:10.2165/00148365-200504020-00001 · Cited by 114 · see citing works
A matching method for improving covariate balance in cost‐effectiveness analyses
Sekhon, J. S., & Grieve, R. (2011) · Health Economics · doi:10.1002/hec.1748 · Cited by 114 · see citing works
Griffin, S., Barber, J., Manca, A., Sculpher, M., Thompson, S., Buxton, M., & Hemingway, H. (2007) · British medical journal · doi:10.1136/bmj.39129.442164.55 · Cited by 114 · see citing works
de Groof, E. J., Stevens, T. W., Eshuis, E. J., Gardenbroek, T. J., Bosmans, J. E., van Dongen, J. M., Mol, B., Buskens, C. J., Stokkers, P. C. F., Hart, A. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317539 · Cited by 106 · see citing works
McCarthy, I., O’Brien, M. F., Ames, C. P., Robinson, C., Errico, T. J., Polly, D. W., & Hostin, R. A. (2014) · Neurosurgical FOCUS · doi:10.3171/2014.3.focus1415 · Cited by 105 · see citing works
Moltó, A., López‐Medina, C., den Bosch, F. E. V., Boonen, A. E. R. C. H., Webers, C., Dernis, E., van Gaalen, F. A., Soubrier, M., Claudepierre, P., Baillet, A. C., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219585 · Cited by 104 · see citing works
Conducting economic evaluations alongside multinational clinical trials: Toward a research consensus
Reed, S., Anstrom, K. J., Bakhai, A., Briggs, A. H., Califf, R. M., Cohen, D. J., Drummond, M., Glick, H. A., Gnanasakthy, A., Hlatky, M. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.11.001 · Cited by 93 · see citing works
Self-citationRegression methods for cost-effectiveness analysis with censored data
Willan, A. R., Lin, D. Y., & Manca, A. (2004) · Statistics in Medicine · doi:10.1002/sim.1794 · Cited by 92 · see citing works
Self-citationLittlewood, E., Duarte, A., Hewitt, C. E., Knowles, S. E., Palmer, S., Walker, S., Andersen, P., Araya, R., Barkham, M., Bower, P., et al. (2015) · Health Technology Assessment · doi:10.3310/hta191010 · Cited by 94 · see citing works
Harvey, S. E., Parrott, F., Harrison, D. A., Sadique, Z., Grieve, R., Canter, R. R., McLennan, B. K., Tan, J. C., Bear, D. E., Segaran, E., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20280 · Cited by 91 · see citing works
Turner, D. A., Khioe, R. F. S., Shepstone, L., Lenaghan, E., Cooper, C. C., Gittoes, N. J. L., Harvey, N. C., Holland, R., Howe, A. C., McCloskey, E. V., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3381 · Cited by 88 · see citing works
Radford, K., Sutton, C., Sach, T., Holmes, J. A., Watkins, C. L., Forshaw, D., Jones, T. M., Hoffman, K., O’Connor, R. J., Tyerman, R., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22330 · Cited by 83 · see citing works
Williams, M. A., Williamson, E. M., Heine, P., Nichols, V. P., Glover, M. J., Dritsaki, M., Adams, J., Dosanjh, S., Underwood, M. R., Rahman, A., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19190 · Cited by 84 · see citing works
How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?
Thompson, S., & Nixon, R. (2005) · Medical decision making · doi:10.1177/0272989x05276862 · Cited by 92 · see citing works
Brown, S. R., Tiernan, J. P., Biggs, K., Hind, D., Shephard, N., Bradburn, M. J., Wailoo, A., Alshreef, A., Swaby, L., Watson, A. J. M., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20880 · Cited by 76 · see citing works
Cost-effectiveness of full endoscopic versus open discectomy for sciatica
Gadjradj, P. S., Broulíková, H. M., van Dongen, J. M., Rubinstein, S. M., Depauw, P. R. A. M., Vleggeert-Lankamp, C. L. A., Seiger, A., Peul, W. C., van Susante, J. L., van Tulder, M. W., et al. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-104808 · Cited by 73 · see citing works
A Pragmatic Multicentered Randomized Controlled Trial of Yoga for Chronic Low Back Pain
Chuang, L., Soares, M. O., Tilbrook, H. E., Cox, H., Hewitt, C. E., Aplin, J., Semlyen, A., Trewhela, A., Watt, I. S., & Torgerson, D. J. (2012) · Spine · doi:10.1097/brs.0b013e3182545937 · Cited by 72 · see citing works
The statistical approach in trial-based economic evaluations matters: get your statistics together!
Mutubuki, E. N., Alili, M. E., Bosmans, J. E., Oosterhuis, T., Snoek, F. J., Ostelo, R., van Tulder, M. W., & van Dongen, J. M. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06513-1 · Cited by 72 · see citing works
D’Amico, F., Rehill, A., Knapp, M. R. J., Aguirre, E., Donovan, H., Hoare, Z., Hoe, J., Russell, I. T., Spector, A. E., Streater, A., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.020 · Cited by 70 · see citing works
Acknowledging Patient Heterogeneity in Economic Evaluation
Grutters, J. P. C., Sculpher, M. J., Briggs, A. H., Severens, J. L., Candel, M. J. J. M., Stahl, J. E., Ruysscher, D. D., Boer, A., Ramaekers, B. L. T., & Joore, M. A. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0015-4 · Cited by 70 · see citing works
Self-citationBehavioural activation therapy for post-stroke depression: the BEADS feasibility RCT
Thomas, S., Drummond, A. E., Lincoln, N. B., Palmer, R., das Nair, R., Latimer, N. R., Hackney, G., Mandefield, L., Walters, S. J., Hatton, R. D., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23470 · Cited by 67 · see citing works
Jha, S., Walters, S. J., Bortolami, O., Dixon, S., & Alshreef, A. (2017) · Physiotherapy · doi:10.1016/j.physio.2017.06.003 · Cited by 64 · see citing works
Iliffe, S., Wilcock, J., Drennan, V. M., Goodman, C. M., Griffin, M., Knapp, M. R. J., Lowery, D., Manthorpe, J., Rait, G., & Warner, J. P. (2015) · Programme Grants for Applied Research · doi:10.3310/pgfar03030 · Cited by 63 · see citing works
GALA Collaborative Group, Gomes, M., Soares, M. O., Dumville, J. C., Lewis, S. C., Torgerson, D. J., Bodenham, A. R., Gough, M. J., & Warlow, C. P. (2010) · British journal of surgery · doi:10.1002/bjs.7110 · Cited by 62 · see citing works
Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials
Gomes, M., Grieve, R., Nixon, R. M., & Edmunds, W. J. (2011) · Medical Decision Making · doi:10.1177/0272989x11407341 · Cited by 60 · see citing works
Vu, T., Harris, A., Duncan, G., & Sussman, G. (2007) · Family Practice · doi:10.1093/fampra/cmm024 · Cited by 59 · see citing works
An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis
Franklin, M., Lomas, J., Walker, S., & Young, T. (2019) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-019-00771-y · Cited by 48 · see citing works
Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy
van Waart, H., van Dongen, J. M., van Harten, W. H., Stuiver, M. M., Huijsmans, R., Hellendoorn-van Vreeswijk, J. A. J. H., Sonke, G. S., & Aaronson, N. K. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-017-0936-0 · Cited by 56 · see citing works
Maguire, A., Clarkson, J. E., Douglas, G. V., Ryan, V., Homer, T., Marshman, Z., McColl, E., Wilson, N., Vale, L., Robertson, M., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24010 · Cited by 55 · see citing works
Thomas, K. S., Bradshaw, L. E., Sach, T., Batchelor, J., Lawton, S., Harrison, E., Haines, R., Ahmed, A. I., Williams, H. C., Dean, T., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002280 · Cited by 55 · see citing works
Palmer, R., Dimairo, M., Latimer, N., Cross, E., Brady, M., Enderby, P., Bowen, A., Julious, S., Harrison, M., Alshreef, A., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24190 · Cited by 53 · see citing works
Cost-effectiveness analysis for multinational clinical trials
Pinto, E. M., Willan, A. R., & OʼBrien, B. J. (2005) · Statistics in Medicine · doi:10.1002/sim.2078 · Cited by 53 · see citing works
Self-citationKreif, N., Grieve, R., & Sadique, Z. (2012) · Health Economics · doi:10.1002/hec.2806 · Cited by 51 · see citing works
Panel Data Methods and Applications to Health Economics
Jones, A. M. (2009) · Palgrave Macmillan UK eBooks · doi:10.1057/9780230244405_12 · Cited by 51 · see citing works
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT
Coomarasamy, A., Harb, H. M., Devall, A., Cheed, V., Roberts, T. E., Goranitis, I., Ogwulu, C. B., Williams, H., Gallos, I. D., Eapen, A. K., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24330 · Cited by 51 · see citing works
Eriksson, J. K., Karlsson, J. A., Bratt, J., Petersson, I. F., van Vollenhoven, R., Ernestam, S., Geborek, P., & Neovius, M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205060 · Cited by 50 · see citing works
METHODS FOR COVARIATE ADJUSTMENT IN COST‐EFFECTIVENESS ANALYSIS THAT USE CLUSTER RANDOMISED TRIALS
Gomes, M., Grieve, R., Nixon, R. M., Ng, E. S. W., Carpenter, J. R., & Thompson, S. G. (2012) · Health Economics · doi:10.1002/hec.2812 · Cited by 50 · see citing works
Conducting Trial-Based Economic Evaluations Using R: A Tutorial
Ben, Â. J., van Dongen, J. M., Alili, M. E., Eßer, J., Broulíková, H. M., & Bosmans, J. E. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01301-7 · Cited by 48 · see citing works
Kreif, N., Grieve, R., Radice, R., & Sekhon, J. S. (2013) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-013-0109-2 · Cited by 48 · see citing works
Ramaekers, B. L. T., Joore, M. A., & Grutters, J. P. C. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.013 · Cited by 47 · see citing works
Optimal treatment for obsessive compulsive disorder
Fineberg, N. A., Baldwin, D. S., Drummond, L. M., Wyatt, S., Hanson, J., Gopi, S., Kaur, S., Reid, J. E., Marwah, V., Sachdev, R. A., et al. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000237 · Cited by 47 · see citing works
Statistical analysis of cost–effectiveness data from randomized clinical trials
Willan, A. R. (2006) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.6.3.337 · Cited by 47 · see citing works
Self-citationManca, A., Lambert, P. C., Sculpher, M. J., & Rice, N. (2007) · Medical Decision Making · doi:10.1177/0272989x07302132 · Cited by 46 · see citing works
Harding, C., Chadwick, T. J., Homer, T. M., Lecouturier, J., Mossop, H., Carnell, S. C., King, W. J., Abouhajar, A., Vale, L. D., Watson, G. C., et al. (2022) · Health Technology Assessment · doi:10.3310/qoiz6538 · Cited by 46 · see citing works
van Dongen, J. M., Persoon, S., Jongeneel, G., Bosmans, J. E., Kersten, M. J., Brug, J., Nollet, F., Chinapaw, M. J. M., & Buffart, L. M. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00775-9 · Cited by 45 · see citing works
Towards Causal Benchmarking of Bias in Face Analysis Algorithms
Balakrishnan, G., Xiong, Y., Xia, W., & Perona, P. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-58523-5_32 · Cited by 45 · see citing works
Taylor, S. J., Carnes, D., Homer, K., Pincus, T., Kahan, B. C., Hounsome, N., Eldridge, S., Spencer, A., Diaz-Ordaz, K., Rahman, A., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04140 · Cited by 44 · see citing works
Eckermann, S. D., & Willan, A. R. (2011) · PharmacoEconomics · doi:10.2165/11587100-000000000-00000 · Cited by 44 · see citing works
Self-citationMethods for analyzing cost effectiveness data from cluster randomized trials
Bachmann, M. O., Fairall, L. R., Clark, A., & Mugford, M. (2007) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-5-12 · Cited by 44 · see citing works
Dakin, H., & Gray, A. M. (2017) · Statistics in Medicine · doi:10.1002/sim.7322 · Cited by 43 · see citing works
Fredborg, C., Odgaard, A., & Sørensen, J. R. (2020) · The Bone & Joint Journal · doi:10.1302/0301-620x.102b4.bjj-2018-1580.r3 · Cited by 43 · see citing works
Batchelor, J., Millington, A., Thomas, K. S., Akram, P., Azad, J., Bewley, A., Chalmers, J. R., Cheung, S. T., Duley, L., Eleftheriadou, V., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24640 · Cited by 43 · see citing works
Thomas, K. S., Bradshaw, L. E., Sach, T., Cowdell, F., Batchelor, J., Lawton, S., Harrison, E., Haines, R., Ahmed, A. I., Dean, T., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21160 · Cited by 43 · see citing works
Using propensity scores to estimate the cost–effectiveness of medical therapies
Indurkhya, A., Mitra, N., & Schrag, D. (2005) · Statistics in Medicine · doi:10.1002/sim.2267 · Cited by 42 · see citing works
Alili, M. E., van Dongen, J. M., Eßer, J., Heymans, M. W., van Tulder, M. W., & Bosmans, J. E. (2022) · Health Economics · doi:10.1002/hec.4603 · Cited by 41 · see citing works
Rosner, R., Sachser, C., Hornfeck, F., Kilian, R., Kindler, H., Muche, R., Müller, L. R. F., Thielemann, J., Waldmann, T., Ziegenhain, U., et al. (2020) · Trials · doi:10.1186/s13063-020-04922-x · Cited by 40 · see citing works
Patel, S., Ngunjiri, A. S. W., Hee, S. W., Yang, Y., Brown, S., Friede, T., Griffiths, F. E., Lord, J. L., Sandhu, H. K., Thistlethwaite, J. E., et al. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-282 · Cited by 40 · see citing works
Radford, K., Craven, K., McLellan, V., Sach, T., Brindle, R., Holloway, I., Hartley, S., Bowen, A., O’Connor, R. J., Stevens, J., et al. (2020) · Trials · doi:10.1186/s13063-020-04883-1 · Cited by 39 · see citing works
Knapp, M. R. J., Windmeijer, F. A. G., Brown, J., Kontodimas, S., Tzivelekis, S., Haro, J. M., Ratcliffe, M., Hong, J., & Novick, D. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826040-00006 · Cited by 37 · see citing works
Suman, A., Schaafsma, F. G., van Dongen, J. M., Elders, P. J. M., Buchbinder, R., van Tulder, M. W., & Anema, J. R. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030879 · Cited by 36 · see citing works
Alili, M. E., van Dongen, J. V., Goldfeld, K. S., Heymans, M., van Tulder, M. V., & Bosmans, J. (2020) · PharmacoEconomics (Auckland) · doi:10.1007/s40273-020-00946-y · Cited by 24 · see citing works
Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
Hemming, C., Constable, L., Goulao, B., Kilonzo, M., Boyers, D., Elders, A., Cooper, K., Smith, A., Freeman, R., Breeman, S., et al. (2020) · Health Technology Assessment · doi:10.3310/hta24130 · Cited by 35 · see citing works
Average Cost-Effectiveness Ratio with Censored Data
Bang, H., & Zhao, H. (2012) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2010.544437 · Cited by 35 · see citing works
Stratified Patient-Centered Care in Type 2 Diabetes
Slingerland, A. S., Herman, W. H., Redekop, K., Dijkstra, R. F., Jukema, J. W., & Niessen, L. W. (2013) · Diabetes Care · doi:10.2337/dc12-1865 · Cited by 34 · see citing works
Dixon, S., Hill, H. R., Flight, L., Khetrapal, P., Ambler, G., Williams, N. R., Brew‐Graves, C., Kelly, J. D., Catto, J. W. F., iROC Study Team, et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.17255 · Cited by 33 · see citing works
Ulug, P., Hinchliffe, R. J., Sweeting, M. J., Gomes, M., Thompson, M. T., Thompson, S. G., Grieve, R., Ashleigh, R., Greenhalgh, R. M., & Powell, J. T. (2018) · Health Technology Assessment · doi:10.3310/hta22310 · Cited by 33 · see citing works
van de Graaf, V. A., van Dongen, J. M., Willigenburg, N. W., Noorduyn, J. C. A., Butter, I. K., de Gast, A., Saris, D. B. F., van Tulder, M. W., & Poolman, R. W. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100065 · Cited by 33 · see citing works
Leurent, B., Gomes, M., Cro, S., Wiles, N., & Carpenter, J. R. (2019) · Health Economics · doi:10.1002/hec.3963 · Cited by 32 · see citing works
Hoch, J. S. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.04.010 · Cited by 33 · see citing works
Self-citationWilliams, A. J., van Dongen, J. M., Kamper, S. J., O’Brien, K. M., Wolfenden, L., Yoong, S. L., Hodder, R. K., Lee, H., Robson, E. K., Haskins, R., et al. (2018) · European Journal of Pain · doi:10.1002/ejp.1334 · Cited by 32 · see citing works
Multilevel models for estimating incremental net benefits in multinational studies
Grieve, R., Nixon, R. M., Thompson, S. G., & Cairns, J. (2006) · Health Economics · doi:10.1002/hec.1198 · Cited by 32 · see citing works
Ng, E. S. W., Diaz‐Ordaz, K., Grieve, R., Nixon, R. M., Thompson, S. G., & Carpenter, J. R. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280213511719 · Cited by 30 · see citing works
The Analysis of Multinational Cost-Effectiveness Data for Reimbursement Decisions
Manca, A., Sculpher, M. J., & Goeree, R. A. (2010) · PharmacoEconomics · doi:10.2165/11537760-000000000-00000 · Cited by 30 · see citing works
Methods for Estimating Subgroup Effects in Cost-Effectiveness Analyses That Use Observational Data
Kreif, N., Grieve, R., Radice, R., Sadique, Z., Ramsahai, R. R., & Sekhon, J. S. (2012) · Medical Decision Making · doi:10.1177/0272989x12448929 · Cited by 30 · see citing works
Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions
Hoch, J. S., & Dewa, C. S. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725100-00001 · Cited by 30 · see citing works
Self-citationKolovos, S., Kenter, R. M. F., Bosmans, J. E., Beekman, A. T. F., Cuijpers, P. J., Kok, R. N., & van Straten, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.025 · Cited by 29 · see citing works
Karapinar‐Çarkit, F., van der Knaap, R., Bouhannouch, F., Borgsteede, S. D., Janssen, M. J. A., Siegert, C. E. H., Egberts, T. C. G., van den Bemt, P. M. L. A., van Wier, M. F., & Bosmans, J. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174513 · Cited by 29 · see citing works
Assessing the Impact of EQ-5D Country-specific Value Sets on Cost-utility Outcomes
van Dongen, J. M., Ben, Â. J., Finch, A. P., Rossenaar, M. M. M., Biesheuvel-Leliefeld, K. E. M., Apeldoorn, A. T., Ostelo, R., van Tulder, M. W., van Marwijk, H., & Bosmans, J. E. (2020) · Medical Care · doi:10.1097/mlr.0000000000001417 · Cited by 29 · see citing works
Winkler, P., Koeser, L., Kondrátová, L., Broulíková, H. M., Páv, M., Kališová, L., Barrett, B., & McCrone, P. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30388-2 · Cited by 25 · see citing works
Value of Information and Pricing New Healthcare Interventions
Willan, A. R., & Eckermann, S. D. (2012) · PharmacoEconomics · doi:10.2165/11592250-000000000-00000 · Cited by 28 · see citing works
Self-citationStracke, M., Gilbert, K., Kieser, M., Klose, C., Krisam, J., Ebert, D. D., Buntrock, C., & Christiansen, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00054 · Cited by 28 · see citing works
Baka, A., van der Zweerde, T., Lancee, J., Bosmans, J. E., & van Straten, A. (2021) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1901708 · Cited by 28 · see citing works
- Authors
- Willan, A. R., Briggs, A. H., & Hoch, J. S.
- Affiliations
- University of Toronto (CA)
- University of Oxford (GB)
- Western University (CA)
- Corresponding author
- Willan, Andrew R.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2003-12-15
- Volume
- 13
- Issue
- 5
- Pages
- 461-475
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2069086045
- Cited by
- 364
- References
- 33
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 28 · 2023: 20 · 2022: 25 · 2021: 33 · 2020: 44 · 2019: 18 · 2018: 26 · 2017: 24 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 11 · 2012: 10
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Health Economics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Keywords
- cost-effectiveness analysis, covariate adjustment, subgroup analysis, seemingly unrelated regression, individual patient data, incremental cost-effectiveness, incremental net benefit, prognostic factors
- MeSH terms
- Adult, Canada, Cost-Benefit Analysis, Humans, Middle Aged, Regression Analysis, Models, Statistical, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review